We represented a global for-profit health insurance company with more than 20 million members in False Claims Act (FCA) litigation in federal court in the Northern District of Illinois. The case was initiated by a whistleblower who alleged that a contractual relationship between a pharmacy benefit manager and pharmaceutical manufacturer violated the Anti-Kickback Statute (AKS), resulting in the submission of false claims to Medicare Advantage plans. After a lengthy investigation and advocacy by our litigation team, the government declined to intervene in the lawsuit. The whistleblower decided to proceed, and we represented the client in years of contentious litigation, which resulted in a favorable settlement for our client while dispositive motions were pending.
Successful Resolution of FCA Case for Global For-Profit Health Insurance Company
You Also May Be Interested In:
Representation of ED company and other defendants in qui tam lawsuit alleging that ED provider’s violation of licensure laws caused submission of false claims and that defendants fraudulently billed services as performed by physicians even though patients were seen only by nurse practitioners. We obtained dismissal of the licensure claims and received summary judgment as to the upcoding claims. U.S. ex rel. Taylor v. Boyko, 2020 WL 520933 (S.D. W. Va. Jan. 31, 2020); U.S. ex rel. Taylor v. Perni, 2020 WL 2499544 (S.D. W. Va. May 14, 2020).
Representation of Skilled Nursing Facility Company: U.S. ex rel. Wright v. Saber Healthcare Holdings (E.D. Va.)